Research Paper Volume 13, Issue 20 pp 23672—23688

Differences in and verification of genetic alterations in chemotherapy and immunotherapy for metastatic melanoma

class="figure-viewer-img"

Figure 1. Cumulative number of survived events in patients with metastatic melanoma undergoing chemotherapy and immunotherapy. (AC) The Log-rank test for overall survival, disease specific survival, and progression-free interval survival curves of the chemotherapy and immunotherapy groups. (D) Survival curves of overall survival of male and female patients.